Evolus Inc Stock
Price
Target price
€7.65
€7.65
-0.640%
-0.05
-0.640%
€15.59
22.03.23 / Tradegate
WKN: A2JDYX / Symbol: EOLS / Name: Evolus / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Evolus Inc Stock
The price for the Evolus Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.050 (-0.640%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Evolus Inc stock is not clear.
With a target price of €15.00 there is a hugely positive potential of 96.078% for Evolus Inc compared to the current price of €7.65.
Our community identified positive and negative aspects for Evolus Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Evolus Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Evolus Inc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Evolus Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evolus Inc | -0.640% | -9.467% | -7.273% | -28.505% | 8.511% | 125.000% | - |
| Krystal Biotech | 5.260% | 0.000% | -6.081% | 13.008% | -7.333% | - | - |
| Hepion Pharmaceuticals Inc. | 1.610% | -9.743% | -14.700% | -37.288% | 139.427% | -59.238% | - |
| Champions Oncology Inc | 6.810% | -13.364% | -12.150% | -50.850% | -8.738% | -28.381% | - |
Comments
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
Show more
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EOLS provided by MarketBeat
